Peter D. O'Hanley
Corporate Officer/Principal chez Stanford University
Profil
Peter D.
O'Hanley was Senior Vice President of Clinical Development and Regulatory Affairs for AVI BioPharma, Inc. from March 2004 to January 9, 2009.
From 2002 to 2003, he was Vice President of Clinical Development for Maxygen, Inc. and Chief Scientific Officer of Preventis, Inc. from 2000 to 2003.
Dr. O'Hanley was Vice President and Chief Scientific Officer of the Anti-Infective Therapeutic & Immunology Therapeutic Groups for Quintiles, Inc. from 1998 to 2000.
He was a Visiting Clinical Scientist of Shaman Pharmaceuticals from 1996 to 1997 and an Associate Professor at the Stanford University School of Medicine from 1985 to 1998.
Dr. O'Hanley received a BA degree in Zoology from Pomona College, a PhD in Anatomy and an MD from the Medical University of South Carolina and an MPH in Epidemiology from the University of California at Berkeley.
Postes actifs de Peter D. O'Hanley
| Sociétés | Poste | Début |
|---|---|---|
| Stanford University | Corporate Officer/Principal | 01/01/1985 |
Anciens postes connus de Peter D. O'Hanley
| Sociétés | Poste | Fin |
|---|---|---|
| SAREPTA THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 09/01/2009 |
Maxygen, Inc.
 Maxygen, Inc. Miscellaneous Commercial ServicesCommercial Services Maxygen, Inc. is a biotechnology company. It is focused on the potential further development of its MAXY-G34 product, a next-generation pegylated, granulocyte colony stimulating factor, G-CSF, for the treatment of chemotherapy induced neutropenia and acute radiation syndrome. G-CSF is a natural protein that functions by stimulating the body's bone marrow to produce more white blood cells. The company was founded on May 7, 1996 and is headquartered in San Mateo, CA. | Directeur Technique/Scientifique/R&D | 01/01/2003 |
| Preventis, Inc. | Directeur Technique/Scientifique/R&D | 01/01/2003 |
Quintiles, Inc. (California)
 Quintiles, Inc. (California) Medical/Nursing ServicesHealth Services Quintiles, Inc. provides therapeutic services. It offers medical services, information and partnering solutions to the pharmaceutical, biotechnology and healthcare industries. The company was founded in 1982 and is headquartered in San Francisco, CA. | Corporate Officer/Principal | 01/01/2000 |
Formation de Peter D. O'Hanley
| Pomona College | Undergraduate Degree |
| Medical University of South Carolina | Doctorate Degree |
| University of California, Berkeley | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| SAREPTA THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Maxygen, Inc.
Maxygen, Inc. Miscellaneous Commercial ServicesCommercial Services Maxygen, Inc. is a biotechnology company. It is focused on the potential further development of its MAXY-G34 product, a next-generation pegylated, granulocyte colony stimulating factor, G-CSF, for the treatment of chemotherapy induced neutropenia and acute radiation syndrome. G-CSF is a natural protein that functions by stimulating the body's bone marrow to produce more white blood cells. The company was founded on May 7, 1996 and is headquartered in San Mateo, CA. | Commercial Services |
Quintiles, Inc. (California)
Quintiles, Inc. (California) Medical/Nursing ServicesHealth Services Quintiles, Inc. provides therapeutic services. It offers medical services, information and partnering solutions to the pharmaceutical, biotechnology and healthcare industries. The company was founded in 1982 and is headquartered in San Francisco, CA. | Health Services |
| Preventis, Inc. |
